Download Citation
Article Source:
Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study
Pomej K,
Frick A,
Scheiner B,
Balcar L,
Pajancic L,
et al.
(2025)
Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study.
PLOS ONE 20(4): e0321189.
https://doi.org/10.1371/journal.pone.0321189